Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out

By Thomas Niel, InvestorPlace Contributor

Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid.

Square Stock is Still Vulnerable, and Could Keep Sliding Lower

By Thomas Niel, InvestorPlace Contributor

Strong long-term prospects notwithstanding, SQ stock has more room to drop in the near-term. Even if you believe recent concerns are overblown, waiting for more weakness may be the best move.

The Upcoming Delisting Makes Didi Global Stock a Pure Gamble

By Thomas Niel, InvestorPlace Contributor

You may want to at least wait for DIDI stock to move over to the OTC market before you decide to buy the shares.

Market Direction Will Determine Where Cardano Heads Next

By Thomas Niel, InvestorPlace Contributor

Cardano continues to make progress becoming more widely used. Crypto market trends will determine whether it rebounds, or dips further.

Sundial Growers Has More Than One Way Back to Higher Prices

By Thomas Niel, InvestorPlace Contributor

With its M&A and investments yet another sign it's making the right moves, SNDL stock is looking more promising.

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts

By Thomas Niel, InvestorPlace Contributor

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.

Even if You’re Bullish on the Metaverse, Tread Carefully With Decentraland

By Thomas Niel, InvestorPlace Contributor

Between the risk of pulling back further in the short-term, and its debatable long-term potential, be careful with Decentraland right now.

Stellar Cyber Monday Numbers Confirm Shopify Stock Still Has It

By Thomas Niel, InvestorPlace Contributor

Based on its recent performance, you may be wary about buying SHOP stock today. But given the underlying "story" remains intact, and an upcoming product launch could kick it back into high gear, I wouldn't write it off just yet.

Wait for the Meta Madness to Cool Before Buying Matterport Stock

By Thomas Niel, InvestorPlace Contributor

MTTR stock may give you exposure to the metaverse trend, but the shares have become 'priced for perfection' because of it.

Wait for the Dip Before Buying Gores Guggenheim

By Thomas Niel, InvestorPlace Contributor

Electric vehicle play GGPI stock looks promising, but it's best to only enter a position at or below its SPAC offering price.

Load More